LANADELUMAB-FLYO | B761090 | DYAX CORP.
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Aug. 23, 2030 | Active | Computed |
| 7-Year Orphan | Feb. 3, 1930 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12442824(diagnostic) · relevance 78/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 82 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.